• About Us
  • Development history
  • R&D Center
  • Quality Department lab
  • Corporation Culture
  • Organization Structure
  • Qualifications & Accreditations
  • Supply of Characteristic APIs and intermediates

        As a high-tech enterprise invested by Anhui CHICO Chemical Co., Ltd., Anqing CHICO Pharmaceutical Co., Ltd is mainly engaged in the CRO/CDMO service of APIs and production of high-end pharmaceutical intermediates. Since inception, we have devoted ourselves to the research, development and production of small molecule targeted anti-tumor, anti-diabetic APIs, and pharmaceutical intermediates.


        Regarding quality as number one priority, we have established a strict quality assurance system reference to GMP requirements. In accordance with the requirements of relevant EHS laws and regulations of China, we also have established a sound EHS management system and strive to create a safe, healthy, and clean working environment for our employees to achieve sustainable development.


        Adhering to the business philosophy of "Consummate Service Convincing Honor", we strive to provide quality products and first-class service for customers relying on profound technical accumulation and outstanding professional quality. We sincerely welcome new and old customers at home and abroad to conduct business relations with us. We sincerely look forward to continuously enhancing mutual friendship through honest, high-quality, high- efficient and professional service. We will work with you to create a bright future!


The R&D center is located at Jiangsu life Science& Technology Innovation Park,with a total floorage of 1800m2.

It has a dedicated and dynamic R&D team of 30+ technicians, which is experienced in API registration and application, and has conducted for more than 50 APIs.

R&D center facility:

20+fume hoods,

2 pilot scale laboratories equipped with 6 reactors(20-100L) ;

Analysis equipment:

GC/HPLC, GC-MS,LC-MS, ICP-MS, Polarimeter, UV-Vis, Melting point apparatus, Rapid moisture tester, Drug stability test chamber



The company's quality policy is "Pursue excellence with sustainable innovations ". That is, to produce qualified products is our obligation to the society, the pursuit of quality excellence is our dedication to the society.

We continue to improve our research and development efforts to provide high-quality products and services;

We accelerate the establishment of a scientific and efficient management system with continuous improvement for the maximum development and benefits of the enterprise.

We regard Quality as everyone's responsibility, and each of us is obliged to do everything correctly, efficiently and comprehensively.


Our Vision:

----To be the leading company of China for the research and development, production and marketing of pharmaceutical new drugs;


Business philosophy:

----Consummate Service

----Convincing Honor


Quality policy:

----continue to innovate

----Pursue to excellence


Talent Concept

Science & technology is the first productivity; scientific and technical talent is the first resource;

Create an inclusive, fair, focused and innovative work environment; Provide staff with equal opportunities for development and broad space.

Supply of Characteristic APIs and intermediates


Small molecule anti-tumor category --- tinib

Nilotinib, Pazopanib, Gefitinib, Erlotinib, Lapatinib, Ibrutinib, Sunitinib, Dasatinib, Palbocilib, Bosutinib Sorafenib, Axitinib, Vandetanib, Afatinib, Lenvatinib, Cabozantinib, Nintedanib、AZD9291, Ceritinib etc.



Anti-diabetic category--- gliptin,-gliflozin

Alogliptin /Trelagliptin, Linagliptin, Canagliflozin, Dapagliflozin, Empagliflozin, Luseogliflozin etc.



Anti- cardiovascular category--- xaban

Apixaban,Rivaroxaban,   Edoxaban etc.